• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动静脉血浆浓度差在清除率研究中的意义。

The significance of the arterial-venous plasma concentration difference in clearance studies.

作者信息

Chiou W L, Lam G

出版信息

Int J Clin Pharmacol Ther Toxicol. 1982 May;20(5):197-203.

PMID:7095918
Abstract

Arterial-venous blood or plasma concentration differences and their implications for renal clearance studies are reviewed. In common practice peripheral venous blood or plasma is used for absolute clearance studies employing timed-interval methods following single dosing. However, this is theoretically inappropriate or incorrect because of the systemic arterial-venous blood or plasma concentration difference. Many examples showing arterial-venous differences, together with brief theoretical discussions of factors affecting the differences, are presented. The implications in clearance studies of other organs such as lungs, liver, and the gastrointestinal tract are also discussed.

摘要

本文综述了动静脉血或血浆浓度差异及其对肾脏清除率研究的影响。在常规实践中,外周静脉血或血浆用于单次给药后采用定时间隔法的绝对清除率研究。然而,由于体循环动静脉血或血浆浓度差异,这在理论上是不合适或不正确的。文中给出了许多显示动静脉差异的例子,并对影响这些差异的因素进行了简要的理论讨论。还讨论了肺、肝和胃肠道等其他器官在清除率研究中的意义。

相似文献

1
The significance of the arterial-venous plasma concentration difference in clearance studies.动静脉血浆浓度差在清除率研究中的意义。
Int J Clin Pharmacol Ther Toxicol. 1982 May;20(5):197-203.
2
Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration.
Res Commun Chem Pathol Pharmacol. 1981 Apr;32(1):27-39.
3
Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body.
Res Commun Chem Pathol Pharmacol. 1982 Jan;35(1):17-26.
4
Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
Res Commun Chem Pathol Pharmacol. 1981 Jul;33(1):33-48.
5
The physiological significance of the apparent volume of distribution, Vdarea or Vd beta, in pharmacokinetic studies.
Res Commun Chem Pathol Pharmacol. 1981 Sep;33(3):499-508.
6
[Role of clinical pharmacokinetics in the causal treatment of acute drug poisoning].[临床药代动力学在急性药物中毒因果治疗中的作用]
Bull Mem Acad R Med Belg. 1981;136(8-9):443-72.
7
New physiologically based methods for calculating the apparent steady-state volume of distribution in pharmacokinetic studies.药代动力学研究中计算表观稳态分布容积的新的基于生理学的方法。
Int J Clin Pharmacol Ther Toxicol. 1982 Jun;20(6):255-8.
8
Differences in arterial and mixed venous IL-6 levels: the lungs as a source of cytokine storm in sepsis.动脉血与混合静脉血中白细胞介素-6水平的差异:肺作为脓毒症细胞因子风暴的来源
Surgery. 2001 Oct;130(4):748-51; discussion 751-2. doi: 10.1067/msy.2001.118094.
9
Clearance and bioavailability study through arterio-venous drug concentrations relationship.经动静脉药物浓度关系的清除率和生物利用度研究。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):825-9. doi: 10.1016/j.ejps.2013.01.016. Epub 2013 Feb 9.
10
Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.肾脏对丙泊酚在人体中的肝外清除有作用,但肺和脑没有。
Br J Clin Pharmacol. 2005 Aug;60(2):176-82. doi: 10.1111/j.1365-2125.2005.02393.x.

引用本文的文献

1
The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.动静脉浓度差异对药效学参数估计值的影响。
J Pharmacokinet Biopharm. 1997 Feb;25(1):39-62. doi: 10.1023/a:1025767710234.
2
Pharmacokinetics of pipecuronium in infants, children and adults.
Eur J Drug Metab Pharmacokinet. 1995 Jul-Sep;20(3):203-8. doi: 10.1007/BF03189671.
3
Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.多次剂量输注后兔体内甲氨蝶呤和7-羟基甲氨蝶呤的清除率研究。
J Pharmacokinet Biopharm. 1983 Oct;11(5):515-27. doi: 10.1007/BF01062209.
4
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.静脉注射后甲氨蝶呤和7-羟基甲氨蝶呤在兔体内的药代动力学
J Pharmacokinet Biopharm. 1983 Oct;11(5):499-513. doi: 10.1007/BF01062208.
5
Comparison of venous and capillary blood sampling for the clinical determination of tobramycin serum concentrations.用于临床测定妥布霉素血清浓度的静脉血与毛细血管血采样的比较。
Br J Clin Pharmacol. 1985 Dec;20(6):597-601. doi: 10.1111/j.1365-2125.1985.tb05117.x.
6
Urinary pH and urine flow independent renal clearance of methotrexate in dogs.犬尿液pH值和尿流量对甲氨蝶呤肾脏清除率的影响(独立因素)
J Pharmacokinet Biopharm. 1985 Apr;13(2):159-71. doi: 10.1007/BF01059396.
7
Renal excretion of intravenously infused amoxycillin and ampicillin.静脉输注阿莫西林和氨苄西林后的肾脏排泄情况。
Br J Clin Pharmacol. 1985 Feb;19(2):191-201. doi: 10.1111/j.1365-2125.1985.tb02631.x.
8
The uptake and elution of lignocaine and procainamide in the hindquarters of the sheep described using mass balance principles.运用质量平衡原理描述了利多卡因和普鲁卡因酰胺在绵羊后肢中的摄取和洗脱情况。
J Pharmacokinet Biopharm. 1988 Feb;16(1):31-40. doi: 10.1007/BF01061861.
9
The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).药物浓度对采血部位显著依赖的现象及原理。在药代动力学、药效学、毒理学及治疗学中的意义(第二部分)
Clin Pharmacokinet. 1989 Oct;17(4):275-90. doi: 10.2165/00003088-198917040-00005.
10
Constant-rate intravenous infusion methods for estimating steady-state volumes of distribution and mean residence times in the body for drugs undergoing reversible metabolism.用于估算经历可逆代谢的药物在体内的稳态分布容积和平均驻留时间的恒速静脉输注方法。
Pharm Res. 1990 Jun;7(6):628-32. doi: 10.1023/a:1015874329265.